Sublingual Tablet Immunotherapy in the Treatment of Allergic Rhinitis and Rhinoconjunctivitis: The Role of the Pediatric Care Team
hosted byIntegrity Continuing Education Inc.Sublingual Tablet Immunotherapy in the Treatment of Allergic Rhinitis and Rhinoconjunctivitis: The Role of the Pediatric Care Team is organized by Integrity Continuing Education Inc..
Release date: 17- 03- 2023
Expiration date: 17-03- 2024
Program Overview:
What are the principal methods for the treatment of allergic rhinitis (AR) and allergic rhinitis with conjunctivitis (AR/C) for patients in your practice? Allergen avoidance and environmental measures, symptom-relieving therapy, and allergen immunotherapy are perhaps the best tools to improve the lives of patients. Treatment in the pediatric setting is most frequently focused on symptom-relieving therapy, which provides insufficient relief for many patients. Allergen immunotherapy, when appropriately implemented, has been shown to alter the course of disease and provide long-term symptom relief. However, patient selection criteria, access to specialty-treatment, and other barriers have complicated its use in the pediatric setting. Recent advances in the diagnosis and treatment of AR and AR/C support improved diagnosis and care of patients with inadequate relief from symptom-relieving therapies, including broadly available specific immunoglobulin E (IgE) tests, advances in understanding of immune mechanisms, and newer allergen immunotherapies including oral tablet immunotherapy. This program will review these important updates for pediatric care providers.
Learning Objectives:
Upon completion of this educational activity, participants should be able to:
• Discuss the burden of symptoms of AR/C and the associated impacts on quality of life in children and adolescents
• Implement strategies for the early diagnosis and optimal assessment of AR/C in the pediatric setting
• Describe the role of allergy immunotherapy in the management of patients with AR/C
• Utilize available therapies to achieve optimal management of pediatric patients with AR/C
Additional details will be posted as soon as information is available.
